-
1
-
-
34547122001
-
The 2007 WHO classification of tumours of the central nervous system
-
D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114 2007 97 109
-
(2007)
Acta Neuropathol.
, vol.114
, pp. 97-109
-
-
Louis, D.N.1
Ohgaki, H.2
Wiestler, O.D.3
Cavenee, W.K.4
Burger, P.C.5
Jouvet, A.6
Scheithauer, B.W.7
Kleihues, P.8
-
2
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A.A. Brandes, J. Gijtenbeek, C. Marosi, C.J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J.G. Cairncross, and R.O. Mirimanoff Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol. 10 2009 459 466
-
(2009)
Lancet Oncol.
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
Van Den Bent, M.J.4
Taphoorn, M.J.5
Janzer, R.C.6
Ludwin, S.K.7
Allgeier, A.8
Fisher, B.9
Belanger, K.10
Hau, P.11
Brandes, A.A.12
Gijtenbeek, J.13
Marosi, C.14
Vecht, C.J.15
Mokhtari, K.16
Wesseling, P.17
Villa, S.18
Eisenhauer, E.19
Gorlia, T.20
Weller, M.21
Lacombe, D.22
Cairncross, J.G.23
Mirimanoff, R.O.24
more..
-
3
-
-
33745165285
-
Present and potential future issues in glioblastoma treatment
-
F. Lefranc, N. Sadeghi, I. Camby, T. Metens, O. Dewitte, and R. Kiss Present and potential future issues in glioblastoma treatment Expert. Rev. Anticancer. Ther. 6 2006 719 732
-
(2006)
Expert. Rev. Anticancer. Ther.
, vol.6
, pp. 719-732
-
-
Lefranc, F.1
Sadeghi, N.2
Camby, I.3
Metens, T.4
Dewitte, O.5
Kiss, R.6
-
4
-
-
84924536171
-
Convection-enhanced delivery for the treatment of glioblastoma
-
M.A. Vogelbaum, and M.K. Aghi Convection-enhanced delivery for the treatment of glioblastoma Neuro-Oncology 17 Suppl. 2 2015 ii3 ii8
-
(2015)
Neuro-Oncology
, vol.17
, pp. ii3-ii8
-
-
Vogelbaum, M.A.1
Aghi, M.K.2
-
6
-
-
33845218355
-
Dendritic cell vaccination in patients with malignant gliomas: Current status and future directions
-
(discussioin 999-1000)
-
S. de Vleeschouwer, M. Rapp, R.V. Sorg, H.J. Steiger, W. Stummer, S. van Gool, and M. Sabel Dendritic cell vaccination in patients with malignant gliomas: current status and future directions Neurosurgery 59 2006 988 999 (discussioin 999-1000)
-
(2006)
Neurosurgery
, vol.59
, pp. 988-999
-
-
De Vleeschouwer, S.1
Rapp, M.2
Sorg, R.V.3
Steiger, H.J.4
Stummer, W.5
Van Gool, S.6
Sabel, M.7
-
7
-
-
69949142058
-
Dendritic cell therapy of high-grade gliomas
-
S. Van Gool, W. Maes, H. Ardon, T. Verschuere, S. Van Cauter, and S. De Vleeschouwer Dendritic cell therapy of high-grade gliomas Brain Pathol. 19 2009 694 712
-
(2009)
Brain Pathol.
, vol.19
, pp. 694-712
-
-
Van Gool, S.1
Maes, W.2
Ardon, H.3
Verschuere, T.4
Van Cauter, S.5
De Vleeschouwer, S.6
-
9
-
-
49649113879
-
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
-
S. De Vleeschouwer, S. Fieuws, S. Rutkowski, F. Van Calenbergh, J. Van Loon, J. Goffin, R. Sciot, G. Wilms, P. Demaerel, M. Warmuth-Metz, N. Soerensen, J.E. Wolff, S. Wagner, E. Kaempgen, and S.W. Van Gool Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme Clin. Cancer Res. 14 2008 3098 3104
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 3098-3104
-
-
De Vleeschouwer, S.1
Fieuws, S.2
Rutkowski, S.3
Van Calenbergh, F.4
Van Loon, J.5
Goffin, J.6
Sciot, R.7
Wilms, G.8
Demaerel, P.9
Warmuth-Metz, M.10
Soerensen, N.11
Wolff, J.E.12
Wagner, S.13
Kaempgen, E.14
Van Gool, S.W.15
-
10
-
-
84870982871
-
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
-
S. De Vleeschouwer, H. Ardon, F. Van Calenbergh, R. Sciot, G. Wilms, J. van Loon, J. Goffin, and S. Van Gool Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination Cancer Immunol. Immunother. 61 2012 2105 2112
-
(2012)
Cancer Immunol. Immunother.
, vol.61
, pp. 2105-2112
-
-
De Vleeschouwer, S.1
Ardon, H.2
Van Calenbergh, F.3
Sciot, R.4
Wilms, G.5
Van Loon, J.6
Goffin, J.7
Van Gool, S.8
-
11
-
-
84870985481
-
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: Results of the HGG-2006 phase I/II trial
-
H. Ardon, S.W. Van Gool, T. Verschuere, W. Maes, S. Fieuws, R. Sciot, G. Wilms, P. Demaerel, J. Goffin, F. Van Calenbergh, J. Menten, P. Clement, M. Debiec-Rychter, and S. De Vleeschouwer Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial Cancer Immunol. Immunother. 61 2012 2033 2044
-
(2012)
Cancer Immunol. Immunother.
, vol.61
, pp. 2033-2044
-
-
Ardon, H.1
Van Gool, S.W.2
Verschuere, T.3
Maes, W.4
Fieuws, S.5
Sciot, R.6
Wilms, G.7
Demaerel, P.8
Goffin, J.9
Van Calenbergh, F.10
Menten, J.11
Clement, P.12
Debiec-Rychter, M.13
De Vleeschouwer, S.14
-
12
-
-
84874065710
-
Vaccine strategies for glioblastoma: Progress and future directions
-
C. Jackson, J. Ruzevick, H. Brem, and M. Lim Vaccine strategies for glioblastoma: progress and future directions Immunotherapy 5 2013 155 167
-
(2013)
Immunotherapy
, vol.5
, pp. 155-167
-
-
Jackson, C.1
Ruzevick, J.2
Brem, H.3
Lim, M.4
-
13
-
-
84937434464
-
Current challenges in designing GBM trials for immunotherapy
-
S.P. Weathers, and M.R. Gilbert Current challenges in designing GBM trials for immunotherapy J. Neuro-Oncol. 2015
-
(2015)
J. Neuro-Oncol.
-
-
Weathers, S.P.1
Gilbert, M.R.2
-
14
-
-
69949148057
-
Immunotherapy of diffuse gliomas: Biological background, current status and future developments
-
O.M. Grauer, P. Wesseling, and G.J. Adema Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol. 19 2009 674 693
-
(2009)
Brain Pathol.
, vol.19
, pp. 674-693
-
-
Grauer, O.M.1
Wesseling, P.2
Adema, G.J.3
-
15
-
-
71549114583
-
Galectins and gliomas
-
M. Le Mercier, S. Fortin, V. Mathieu, R. Kiss, and F. Lefranc Galectins and gliomas Brain Pathol. 20 2010 17 27
-
(2010)
Brain Pathol.
, vol.20
, pp. 17-27
-
-
Le Mercier, M.1
Fortin, S.2
Mathieu, V.3
Kiss, R.4
Lefranc, F.5
-
16
-
-
84860801440
-
Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
-
L.G. Toussaint 3rd, A.E. Nilson, J.M. Goble, K.V. Ballman, C.D. James, F. Lefranc, R. Kiss, and J.H. Uhm Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion Mol. Cancer 11 2012 32
-
(2012)
Mol. Cancer
, vol.11
, pp. 32
-
-
Toussaint, L.G.1
Nilson, A.E.2
Goble, J.M.3
Ballman, K.V.4
James, C.D.5
Lefranc, F.6
Kiss, R.7
Uhm, J.H.8
-
17
-
-
12144285871
-
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege
-
N. Rubinstein, M. Alvarez, N.W. Zwirner, M.A. Toscano, J.M. Ilarregui, A. Bravo, J. Mordoh, L. Fainboim, O.L. Podhajcer, and G.A. Rabinovich Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege Cancer cell 5 2004 241 251
-
(2004)
Cancer Cell
, vol.5
, pp. 241-251
-
-
Rubinstein, N.1
Alvarez, M.2
Zwirner, N.W.3
Toscano, M.A.4
Ilarregui, J.M.5
Bravo, A.6
Mordoh, J.7
Fainboim, L.8
Podhajcer, O.L.9
Rabinovich, G.A.10
-
18
-
-
33847376532
-
Galectin-1: A key effector of regulation mediated by CD4 + CD25 + T cells
-
M.I. Garin, C.C. Chu, D. Golshayan, E. Cernuda-Morollon, R. Wait, and R.I. Lechler Galectin-1: a key effector of regulation mediated by CD4 + CD25 + T cells Blood 109 2007 2058 2065
-
(2007)
Blood
, vol.109
, pp. 2058-2065
-
-
Garin, M.I.1
Chu, C.C.2
Golshayan, D.3
Cernuda-Morollon, E.4
Wait, R.5
Lechler, R.I.6
-
19
-
-
84923686047
-
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
-
T. Verschuere, J. Toelen, W. Maes, F. Poirier, L. Boon, T. Tousseyn, T. Mathivet, H. Gerhardt, V. Mathieu, R. Kiss, F. Lefranc, S.W. Van Gool, and S. De Vleeschouwer Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity Int. J. Cancer 2013
-
(2013)
Int. J. Cancer
-
-
Verschuere, T.1
Toelen, J.2
Maes, W.3
Poirier, F.4
Boon, L.5
Tousseyn, T.6
Mathivet, T.7
Gerhardt, H.8
Mathieu, V.9
Kiss, R.10
Lefranc, F.11
Van Gool, S.W.12
De Vleeschouwer, S.13
-
21
-
-
0036289096
-
Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases
-
I. Camby, N. Belot, F. Lefranc, N. Sadeghi, Y. de Launoit, H. Kaltner, S. Musette, F. Darro, A. Danguy, I. Salmon, H.J. Gabius, and R. Kiss Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases J. Neuropathol. Exp. Neurol. 61 2002 585 596
-
(2002)
J. Neuropathol. Exp. Neurol.
, vol.61
, pp. 585-596
-
-
Camby, I.1
Belot, N.2
Lefranc, F.3
Sadeghi, N.4
De Launoit, Y.5
Kaltner, H.6
Musette, S.7
Darro, F.8
Danguy, A.9
Salmon, I.10
Gabius, H.J.11
Kiss, R.12
-
22
-
-
33750474852
-
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
-
V.L. Thijssen, R. Postel, R.J. Brandwijk, R.P. Dings, I. Nesmelova, S. Satijn, N. Verhofstad, Y. Nakabeppu, L.G. Baum, J. Bakkers, K.H. Mayo, F. Poirier, and A.W. Griffioen Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy Proc. Natl. Acad. Sci. U. S. A. 103 2006 15975 15980
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 15975-15980
-
-
Thijssen, V.L.1
Postel, R.2
Brandwijk, R.J.3
Dings, R.P.4
Nesmelova, I.5
Satijn, S.6
Verhofstad, N.7
Nakabeppu, Y.8
Baum, L.G.9
Bakkers, J.10
Mayo, K.H.11
Poirier, F.12
Griffioen, A.W.13
-
23
-
-
43249107550
-
Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses
-
M. Le Mercier, V. Mathieu, B. Haibe-Kains, G. Bontempi, T. Mijatovic, C. Decaestecker, R. Kiss, and F. Lefranc Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses J. Neuropathol. Exp. Neurol. 67 2008 456 469
-
(2008)
J. Neuropathol. Exp. Neurol.
, vol.67
, pp. 456-469
-
-
Le Mercier, M.1
Mathieu, V.2
Haibe-Kains, B.3
Bontempi, G.4
Mijatovic, T.5
Decaestecker, C.6
Kiss, R.7
Lefranc, F.8
-
24
-
-
84888294933
-
Vascular galectins: Regulators of tumor progression and targets for cancer therapy
-
V.L. Thijssen, G.A. Rabinovich, and A.W. Griffioen Vascular galectins: regulators of tumor progression and targets for cancer therapy Cytokine Growth Factor Rev. 24 2013 547 558
-
(2013)
Cytokine Growth Factor Rev.
, vol.24
, pp. 547-558
-
-
Thijssen, V.L.1
Rabinovich, G.A.2
Griffioen, A.W.3
-
25
-
-
43449117183
-
Evidence of galectin-1 involvement in glioma chemoresistance
-
M. Le Mercier, F. Lefranc, T. Mijatovic, O. Debeir, B. Haibe-Kains, G. Bontempi, C. Decaestecker, R. Kiss, and V. Mathieu Evidence of galectin-1 involvement in glioma chemoresistance Toxicol. Appl. Pharmacol. 229 2008 172 183
-
(2008)
Toxicol. Appl. Pharmacol.
, vol.229
, pp. 172-183
-
-
Le Mercier, M.1
Lefranc, F.2
Mijatovic, T.3
Debeir, O.4
Haibe-Kains, B.5
Bontempi, G.6
Decaestecker, C.7
Kiss, R.8
Mathieu, V.9
-
26
-
-
84894136530
-
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
-
D.O. Croci, J.P. Cerliani, T. Dalotto-Moreno, S.P. Mendez-Huergo, I.D. Mascanfroni, S. Dergan-Dylon, M.A. Toscano, J.J. Caramelo, J.J. Garcia-Vallejo, J. Ouyang, E.A. Mesri, M.R. Junttila, C. Bais, M.A. Shipp, M. Salatino, and G.A. Rabinovich Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors Cell 156 2014 744 758
-
(2014)
Cell
, vol.156
, pp. 744-758
-
-
Croci, D.O.1
Cerliani, J.P.2
Dalotto-Moreno, T.3
Mendez-Huergo, S.P.4
Mascanfroni, I.D.5
Dergan-Dylon, S.6
Toscano, M.A.7
Caramelo, J.J.8
Garcia-Vallejo, J.J.9
Ouyang, J.10
Mesri, E.A.11
Junttila, M.R.12
Bais, C.13
Shipp, M.A.14
Salatino, M.15
Rabinovich, G.A.16
-
27
-
-
85027928111
-
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
-
L. Astorgues-Xerri, M.E. Riveiro, A. Tijeras-Raballand, M. Serova, G.A. Rabinovich, I. Bieche, M. Vidaud, A. de Gramont, M. Martinet, E. Cvitkovic, S. Faivre, and E. Raymond OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis Eur. J. Cancer 50 2014 2463 2477
-
(2014)
Eur. J. Cancer
, vol.50
, pp. 2463-2477
-
-
Astorgues-Xerri, L.1
Riveiro, M.E.2
Tijeras-Raballand, A.3
Serova, M.4
Rabinovich, G.A.5
Bieche, I.6
Vidaud, M.7
De Gramont, A.8
Martinet, M.9
Cvitkovic, E.10
Faivre, S.11
Raymond, E.12
-
29
-
-
10344228801
-
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference
-
D.R. Thakker, F. Natt, D. Husken, R. Maier, M. Muller, H. van der Putten, D. Hoyer, and J.F. Cryan Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference Proc. Natl. Acad. Sci. U. S. A. 101 2004 17270 17275
-
(2004)
Proc. Natl. Acad. Sci. U. S. A.
, vol.101
, pp. 17270-17275
-
-
Thakker, D.R.1
Natt, F.2
Husken, D.3
Maier, R.4
Muller, M.5
Van Der Putten, H.6
Hoyer, D.7
Cryan, J.F.8
-
30
-
-
0034095651
-
Transport of drugs from the nasal cavity to the central nervous system
-
L. Illum Transport of drugs from the nasal cavity to the central nervous system Eur. J. Pharm. Sci. 11 2000 1 18
-
(2000)
Eur. J. Pharm. Sci.
, vol.11
, pp. 1-18
-
-
Illum, L.1
-
31
-
-
68649090916
-
Nanoparticles for direct nose-to-brain delivery of drugs
-
A. Mistry, S. Stolnik, and L. Illum Nanoparticles for direct nose-to-brain delivery of drugs Int. J. Pharm. 379 2009 146 157
-
(2009)
Int. J. Pharm.
, vol.379
, pp. 146-157
-
-
Mistry, A.1
Stolnik, S.2
Illum, L.3
-
32
-
-
84860193946
-
Intranasal delivery of biologics to the central nervous system
-
J.J. Lochhead, and R.G. Thorne Intranasal delivery of biologics to the central nervous system Adv. Drug Deliv. Rev. 64 2012 614 628
-
(2012)
Adv. Drug Deliv. Rev.
, vol.64
, pp. 614-628
-
-
Lochhead, J.J.1
Thorne, R.G.2
-
33
-
-
84882659385
-
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
-
M. van Woensel, N. Wauthoz, R. Rosiere, K. Amighi, V. Mathieu, F. Lefranc, S.W. van Gool, and S. de Vleeschouwer Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel) 5 2013 1020 1048
-
(2013)
Cancers (Basel)
, vol.5
, pp. 1020-1048
-
-
Van Woensel, M.1
Wauthoz, N.2
Rosiere, R.3
Amighi, K.4
Mathieu, V.5
Lefranc, F.6
Van Gool, S.W.7
De Vleeschouwer, S.8
-
35
-
-
70249139516
-
Chitosan and its salts for mucosal and transmucosal delivery
-
M.C. Bonferoni, G. Sandri, S. Rossi, F. Ferrari, and C. Caramella Chitosan and its salts for mucosal and transmucosal delivery Expert Opin. Drug Deliv. 6 2009 923 939
-
(2009)
Expert Opin. Drug Deliv.
, vol.6
, pp. 923-939
-
-
Bonferoni, M.C.1
Sandri, G.2
Rossi, S.3
Ferrari, F.4
Caramella, C.5
-
36
-
-
0242288486
-
Absorption enhancers for nasal drug delivery
-
S.S. Davis, and L. Illum Absorption enhancers for nasal drug delivery Clin. Pharmacokinet. 42 2003 1107 1128
-
(2003)
Clin. Pharmacokinet.
, vol.42
, pp. 1107-1128
-
-
Davis, S.S.1
Illum, L.2
-
37
-
-
0035901694
-
Clearance characteristics of chitosan based formulations in the sheep nasal cavity
-
R.J. Soane, M. Hinchcliffe, S.S. Davis, and L. Illum Clearance characteristics of chitosan based formulations in the sheep nasal cavity Int. J. Pharm. 217 2001 183 191
-
(2001)
Int. J. Pharm.
, vol.217
, pp. 183-191
-
-
Soane, R.J.1
Hinchcliffe, M.2
Davis, S.S.3
Illum, L.4
-
38
-
-
33749844509
-
Development and characterisation of chitosan nanoparticles for siRNA delivery
-
H. Katas, and H.O. Alpar Development and characterisation of chitosan nanoparticles for siRNA delivery J. Control. Release 115 2006 216 225
-
(2006)
J. Control. Release
, vol.115
, pp. 216-225
-
-
Katas, H.1
Alpar, H.O.2
-
39
-
-
84877965095
-
Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain
-
W. Maes, T. Verschuere, A. Van Hoylandt, L. Boon, and S. Van Gool Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain Clin. Dev. Immunol. 2013 2013 952469
-
(2013)
Clin. Dev. Immunol.
, vol.2013
, pp. 952469
-
-
Maes, W.1
Verschuere, T.2
Van Hoylandt, A.3
Boon, L.4
Van Gool, S.5
-
40
-
-
77957665776
-
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
-
D. Vllasaliu, R. Exposito-Harris, A. Heras, L. Casettari, M. Garnett, L. Illum, and S. Stolnik Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution Int. J. Pharm. 400 2010 183 193
-
(2010)
Int. J. Pharm.
, vol.400
, pp. 183-193
-
-
Vllasaliu, D.1
Exposito-Harris, R.2
Heras, A.3
Casettari, L.4
Garnett, M.5
Illum, L.6
Stolnik, S.7
-
41
-
-
33845784758
-
Blood-brain barrier delivery
-
W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
-
(2007)
Drug Discov. Today
, vol.12
, pp. 54-61
-
-
Pardridge, W.M.1
-
42
-
-
84956686307
-
Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression
-
B. Steelant, R. Farre, P. Wawrzyniak, J. Belmans, E. Dekimpe, H. Vanheel, L. Van Gerven, I. Kortekaas Krohn, D.M. Bullens, J.L. Ceuppens, C.A. Akdis, G. Boeckxstaens, S.F. Seys, and P.W. Hellings Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression J. Allergy Clin. Immunol. 2016
-
(2016)
J. Allergy Clin. Immunol.
-
-
Steelant, B.1
Farre, R.2
Wawrzyniak, P.3
Belmans, J.4
Dekimpe, E.5
Vanheel, H.6
Van Gerven, L.7
Kortekaas Krohn, I.8
Bullens, D.M.9
Ceuppens, J.L.10
Akdis, C.A.11
Boeckxstaens, G.12
Seys, S.F.13
Hellings, P.W.14
-
43
-
-
69949127667
-
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
-
W. Maes, G.G. Rosas, B. Verbinnen, L. Boon, S. De Vleeschouwer, J.L. Ceuppens, and S.W. Van Gool DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma Neuro-Oncology 11 2009 529 542
-
(2009)
Neuro-Oncology
, vol.11
, pp. 529-542
-
-
Maes, W.1
Rosas, G.G.2
Verbinnen, B.3
Boon, L.4
De Vleeschouwer, S.5
Ceuppens, J.L.6
Van Gool, S.W.7
-
44
-
-
77951132901
-
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
-
M.E. Davis, J.E. Zuckerman, C.H. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, and A. Ribas Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 2010 1067 1070
-
(2010)
Nature
, vol.464
, pp. 1067-1070
-
-
Davis, M.E.1
Zuckerman, J.E.2
Choi, C.H.3
Seligson, D.4
Tolcher, A.5
Alabi, C.A.6
Yen, Y.7
Heidel, J.D.8
Ribas, A.9
-
45
-
-
84892624324
-
Chitosan nanoparticles for siRNA delivery: Optimizing formulation to increase stability and efficiency
-
H. Ragelle, R. Riva, G. Vandermeulen, B. Naeye, V. Pourcelle, C.S. Le Duff, C. D'Haese, B. Nysten, K. Braeckmans, S.C. De Smedt, C. Jerome, and V. Preat Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency J. Control. Release 176 2014 54 63
-
(2014)
J. Control. Release
, vol.176
, pp. 54-63
-
-
Ragelle, H.1
Riva, R.2
Vandermeulen, G.3
Naeye, B.4
Pourcelle, V.5
Le Duff, C.S.6
D'Haese, C.7
Nysten, B.8
Braeckmans, K.9
De Smedt, S.C.10
Jerome, C.11
Preat, V.12
-
46
-
-
68949208465
-
Nanocarriers' entry into the cell: Relevance to drug delivery
-
H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
-
(2009)
Cell. Mol. Life Sci.
, vol.66
, pp. 2873-2896
-
-
Hillaireau, H.1
Couvreur, P.2
-
47
-
-
84929938848
-
Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain
-
M. Malhotra, C. Tomaro-Duchesneau, S. Saha, and S. Prakash Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain Methods Mol. Biol. 1141 2014 233 247
-
(2014)
Methods Mol. Biol.
, vol.1141
, pp. 233-247
-
-
Malhotra, M.1
Tomaro-Duchesneau, C.2
Saha, S.3
Prakash, S.4
-
49
-
-
84878145752
-
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
-
D.T. Wiley, P. Webster, A. Gale, and M.E. Davis Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor Proc. Natl. Acad. Sci. U. S. A. 110 2013 8662 8667
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
, pp. 8662-8667
-
-
Wiley, D.T.1
Webster, P.2
Gale, A.3
Davis, M.E.4
-
50
-
-
68749099644
-
The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
-
M.C. Miller, A. Klyosov, and K.H. Mayo The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain Glycobiology 19 2009 1034 1045
-
(2009)
Glycobiology
, vol.19
, pp. 1034-1045
-
-
Miller, M.C.1
Klyosov, A.2
Mayo, K.H.3
-
51
-
-
67649491055
-
Understanding biophysicochemical interactions at the nano-bio interface
-
A.E. Nel, L. Madler, D. Velegol, T. Xia, E.M. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 8 2009 543 557
-
(2009)
Nat. Mater.
, vol.8
, pp. 543-557
-
-
Nel, A.E.1
Madler, L.2
Velegol, D.3
Xia, T.4
Hoek, E.M.5
Somasundaran, P.6
Klaessig, F.7
Castranova, V.8
Thompson, M.9
-
53
-
-
84899714252
-
Breaking barriers. New insights into airway epithelial barrier function in health and disease
-
F. Rezaee, and S.N. Georas Breaking barriers. New insights into airway epithelial barrier function in health and disease Am. J. Respir. Cell Mol. Biol. 50 2014 857 869
-
(2014)
Am. J. Respir. Cell Mol. Biol.
, vol.50
, pp. 857-869
-
-
Rezaee, F.1
Georas, S.N.2
-
54
-
-
1642579659
-
Effect of chitosan on epithelial cell tight junctions
-
J. Smith, E. Wood, and M. Dornish Effect of chitosan on epithelial cell tight junctions Pharm. Res. 21 2004 43 49
-
(2004)
Pharm. Res.
, vol.21
, pp. 43-49
-
-
Smith, J.1
Wood, E.2
Dornish, M.3
-
55
-
-
84883756054
-
Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles
-
T. Kanazawa, F. Akiyama, S. Kakizaki, Y. Takashima, and Y. Seta Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles Biomaterials 34 2013 9220 9226
-
(2013)
Biomaterials
, vol.34
, pp. 9220-9226
-
-
Kanazawa, T.1
Akiyama, F.2
Kakizaki, S.3
Takashima, Y.4
Seta, Y.5
-
56
-
-
84859000580
-
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
-
D.B. Renner, W.H. Frey 2nd, and L.R. Hanson Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway Neurosci. Lett. 513 2012 193 197
-
(2012)
Neurosci. Lett.
, vol.513
, pp. 193-197
-
-
Renner, D.B.1
Frey, W.H.2
Hanson, L.R.3
-
57
-
-
84872931386
-
Intranasal delivery of neural stem/progenitor cells: A noninvasive passage to target intracerebral glioma
-
M. Reitz, M. Demestre, J. Sedlacik, H. Meissner, J. Fiehler, S.U. Kim, M. Westphal, and N.O. Schmidt Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma Stem Cells Transl. Med. 1 2012 866 873
-
(2012)
Stem Cells Transl. Med.
, vol.1
, pp. 866-873
-
-
Reitz, M.1
Demestre, M.2
Sedlacik, J.3
Meissner, H.4
Fiehler, J.5
Kim, S.U.6
Westphal, M.7
Schmidt, N.O.8
-
58
-
-
0038819415
-
Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme
-
H. Wolburg, K. Wolburg-Buchholz, J. Kraus, G. Rascher-Eggstein, S. Liebner, S. Hamm, F. Duffner, E.H. Grote, W. Risau, and B. Engelhardt Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme Acta Neuropathol. 105 2003 586 592
-
(2003)
Acta Neuropathol.
, vol.105
, pp. 586-592
-
-
Wolburg, H.1
Wolburg-Buchholz, K.2
Kraus, J.3
Rascher-Eggstein, G.4
Liebner, S.5
Hamm, S.6
Duffner, F.7
Grote, E.H.8
Risau, W.9
Engelhardt, B.10
|